147 related articles for article (PubMed ID: 25854294)
21. Calculation of prevalence with Markov models: budget impact analysis of thrombolysis for stroke.
Mar J; Sainz-Ezkerra M; Miranda-Serrano E
Med Decis Making; 2008; 28(4):481-90. PubMed ID: 18349439
[TBL] [Abstract][Full Text] [Related]
22. Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke.
Damani RH; Anand S; Asgarisabet P; Bissell C; Savitz S; Suarez JI
Stroke; 2018 Aug; 49(8):2008-2010. PubMed ID: 29991653
[TBL] [Abstract][Full Text] [Related]
23. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
[TBL] [Abstract][Full Text] [Related]
24. Development of a decision-analytic model of stroke care in the United States and Europe.
Chambers MG; Koch P; Hutton J
Value Health; 2002; 5(2):82-97. PubMed ID: 11918824
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of endovascular therapy for acute ischemic stroke.
Chen M
Neurology; 2012 Sep; 79(13 Suppl 1):S16-21. PubMed ID: 23008392
[TBL] [Abstract][Full Text] [Related]
26. Thrombolytic therapy with alteplase for ischaemic stroke.
Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives.
Switzer JA; Demaerschalk BM; Xie J; Fan L; Villa KF; Wu EQ
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):18-26. PubMed ID: 23212458
[TBL] [Abstract][Full Text] [Related]
28. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
[TBL] [Abstract][Full Text] [Related]
29. Is the Cost-Effectiveness of Stroke Thrombolysis Affected by Proportion of Stroke Mimics?
Liberman AL; Choi HJ; French DD; Prabhakaran S
Stroke; 2019 Feb; 50(2):463-468. PubMed ID: 30572813
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of two endovascular treatment strategies vs intravenous thrombolysis.
Bouvy JC; Fransen PS; Baeten SA; Koopmanschap MA; Niessen LW; Dippel DW
Acta Neurol Scand; 2013 May; 127(5):351-9. PubMed ID: 23278859
[TBL] [Abstract][Full Text] [Related]
31. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack.
Alonso de Leciñana M; Fuentes B; Masjuan J; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Egido JA
Int J Stroke; 2012 Apr; 7(3):213-8. PubMed ID: 22098785
[TBL] [Abstract][Full Text] [Related]
32. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
[TBL] [Abstract][Full Text] [Related]
33. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
34. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
[TBL] [Abstract][Full Text] [Related]
35. The future cost of stroke in Ireland: an analysis of the potential impact of demographic change and implementation of evidence-based therapies.
Smith S; Horgan F; Sexton E; Cowman S; Hickey A; Kelly P; McGee H; Murphy S; O'Neill D; Royston M; Shelley E; Wiley M
Age Ageing; 2013 May; 42(3):299-306. PubMed ID: 23302602
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic drugs and ischaemic stroke.
Prescrire Int; 2013 Nov; 22(143):270-1. PubMed ID: 24427842
[TBL] [Abstract][Full Text] [Related]
37. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke.
Moodie ML; Carter R; Mihalopoulos C; Thrift AG; Chambers BR; Donnan GA; Dewey HM
Stroke; 2004 May; 35(5):1041-6. PubMed ID: 15031457
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability.
Ganesh A; Luengo-Fernandez R; Pendlebury ST; Rothwell PM
Stroke; 2018 Oct; 49(10):2430-2436. PubMed ID: 30355105
[TBL] [Abstract][Full Text] [Related]
39. Is it beneficial to increase the provision of thrombolysis?-- a discrete-event simulation model.
Barton M; McClean S; Gillespie J; Garg L; Wilson D; Fullerton K
QJM; 2012 Jul; 105(7):665-73. PubMed ID: 22383688
[TBL] [Abstract][Full Text] [Related]
40. Thrombolysis for ischemic stroke in the United States: data from National Hospital Discharge Survey 1999-2001.
Qureshi AI; Suri MF; Nasar A; He W; Kirmani JF; Divani AA; Prestigiacomo CJ; Low RB
Neurosurgery; 2005 Oct; 57(4):647-54; discussion 647-54. PubMed ID: 16239876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
